Medicinova Inc (MNOV) Annual Balance Sheets

Annual · GAAP · USD millions
Access MNOV quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Medicinova Inc balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent30.81
Short-term Investments, Total0.00
Cash & Short-term Investments30.00
Prepaid Expense And Other Assets Current0.18
Total Current Assets30.99
Equipment/Property/Plant Net0.01
Goodwill net9.60
Other Assets, Noncurrent5.00
In Process Research And Development4.80
Total Assets45.60
Liabilities
Accounts Payable, Current AC0.62
Other Liabilities, Current3.17
Total Current Liabilities3.80
Total Long-term Debt0.00
Other liabilities, Noncurrent0.02
Accrued Liabilities And Other Liabilities Current2.61
Deferred Income Tax Liabilities Net0.20
Total Liabilities4.02
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock480.41
Retained Earnings / Accumulated Deficit-438.75
Other Equity-0.13
Common Stockholder's Equity41.59
Total Stockholder's Equity41.59
Liabilities & Stockholder's Equity45.60
4 historic quarters locked

Sign in to unlock the full Medicinova Inc balance sheet history.

About Medicinova Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-100432

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License